Sangamo BioSciences | Creditori Commerciali





Creditori Commerciali Cambiamento Data
Alaunos Therapeutics USD 843K 34K 2025-09
Alnylam Pharmaceuticals USD 117.59M 15.2M 2025-09
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Amgen USD 20.89B 1.25B 2025-12
Bayer EUR 6.38B 343M 2025-09
BioCryst Pharmaceuticals USD 5.57M 3.02M 2025-09
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 9.12M 7.33M 2025-09
CSL USD 3.46B 484M 2025-06
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 1.04B 183.31M 2025-06
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 9.62B 161M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Merck USD 4.15B 102M 2025-09
Novartis USD 4.56B 49M 2025-09
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 5.02B 142M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
Tectonic Therapeutic USD 1.48M 1.32M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 4.03B 320.8M 2025-09


Sangamo BioSciences Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.